A trial, in which subjects with type 2 diabetes, who qualify for treatment intensification, are given insulin degludec and, additionally, either liraglutide or insulin aspart, both in combination with metformin, with the largest meal. The purpose is to compare efficacy and safety of these two treatments

To compare the efficacy of adding liraglutide versus adding IAsp to the largest meal on top of IDeg OD + metformin in controlling glycaemia.

Kusajili – Centralise les essais cliniques mondiaux